Antibiotics for acute laryngitis in adults.

BACKGROUND This is an updated version of the original review published in Issue 2, 2007 of The Cochrane Library. Acute laryngitis is a common illness worldwide. Diagnosis is often made by case history alone and treatment is often directed toward controlling symptoms. OBJECTIVES To assess the effectiveness and safety of different antibiotic therapies in adults with acute laryngitis. A secondary objective was to report the rates of adverse events associated with these treatments. SEARCH METHODS We searched CENTRAL 2012, Issue 12, MEDLINE (January 1966 to January week 3, 2013), EMBASE (1974 to January 2013), LILACS (1982 to January 2013) and BIOSIS (1980 to January 2013). SELECTION CRITERIA Randomised controlled trials (RCTs) comparing any antibiotic therapy with placebo for acute laryngitis. The main outcome was objective voice scores. DATA COLLECTION AND ANALYSIS Two review authors independently extracted and descriptively synthesised data. MAIN RESULTS Only two trials met the study inclusion criteria after extensive literature searches. One hundred participants were randomised to receive either penicillin V (800 mg twice a day for five days), or an identical placebo, in a study of acute laryngitis in adults. A tape recording of each patient reading a standardised text was obtained during the first visit, subsequently during re-examination after one and two weeks, and at follow-up after two to six months. No significant differences were found between the groups. The trial also measured symptoms reported by participants and found no significant differences.The second trial investigated erythromycin for treating acute laryngitis in 106 adults. The mean objective voice scores measured at the first visit, at re-examination after one and two weeks, and at follow-up after two to six months did not significantly differ between control and intervention groups. At one week there were significant beneficial differences in the severity of reported vocal symptoms as judged by the participants (P = 0.042). Comparing the erythromycin and placebo groups on subjective voice scores, the a priori risk ratio (RR) was 0.7 (95% confidence interval (CI) 0.51 to 0.96, P = 0.034) and the number needed to treat for an additional beneficial outcome (NNTB) was 4.5. AUTHORS' CONCLUSIONS Antibiotics appear to have no benefit in treating acute laryngitis. Erythromycin could reduce voice disturbance at one week and cough at two weeks when measured subjectively. We consider that these outcomes are not relevant in clinical practice. The implications for practice are that prescribing antibiotics should not be done in the first instance as they will not objectively improve symptoms.

[1]  A. Cardona,et al.  Antibiotics for acute laryngitis in adults. , 2015, Cochrane Database of Systematic Reviews.

[2]  B. Arroll,et al.  Antibiotics for the common cold and acute purulent rhinitis. , 2013, The Cochrane database of systematic reviews.

[3]  J. Darelid,et al.  Reduction of Antibiotics Sales and Sustained Low Incidence of Bacterial Resistance: Report on a Broad Approach During 10 Years to Implement Evidence‐based Indications for Antibiotic Prescribing in Jönköping County, Sweden , 2007, Quality management in health care.

[4]  Chao Sun,et al.  Osteopathic Physicians in the United States: Antibiotic Prescribing Practices for Patients With Nonspecific Upper Respiratory Tract Infections , 2006, The Journal of the American Osteopathic Association.

[5]  S. Straus,et al.  Interventions to improve antibiotic prescribing practices in ambulatory care. , 2005, The Cochrane database of systematic reviews.

[6]  M. Jacobs,et al.  Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. , 2004, Clinics in laboratory medicine.

[7]  Ziyong Sun,et al.  [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[8]  D. Cherry,et al.  National Ambulatory Medical Care Survey: 2001 summary. , 2003, Advance data.

[9]  D. Nadal,et al.  Quantitative Detection of Moraxella catarrhalis in Nasopharyngeal Secretions by Real-Time PCR , 2003, Journal of Clinical Microbiology.

[10]  Ralph Gonzales,et al.  Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. , 2003, JAMA.

[11]  Melissa Morley,et al.  Economic burden of respiratory infections in an employed population. , 2002, Chest.

[12]  J. Bertino.  Cost burden of viral respiratory infections: issues for formulary decision makers. , 2002, The American journal of medicine.

[13]  A. van Belkum,et al.  Moraxella catarrhalis: from Emerging to Established Pathogen , 2002, Clinical Microbiology Reviews.

[14]  H. Milionis,et al.  Effect of Meteorological Parameters on Acute Laryngitis in Adults , 2002, Acta oto-laryngologica.

[15]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Bartlett,et al.  Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. , 2001, Annals of emergency medicine.

[17]  P. Tugwell,et al.  Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? , 2000, The Lancet.

[18]  R. Sataloff,et al.  Acute Laryngitis , 2000, Ear, nose, & throat journal.

[19]  G. Mazzaglia,et al.  Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. , 1998, The Journal of antimicrobial chemotherapy.

[20]  Á. Atallah,et al.  Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS). , 1997, Sao Paulo medical journal = Revista paulista de medicina.

[21]  J. Verhoef,et al.  Moraxella catarrhalis in acute laryngitis: infection or colonization? , 1996, The Journal of infectious diseases.

[22]  Aul,et al.  Development and Validation of a Multiplex PCR-Based Assay for the Upper Respiratory Tract Bacterial Pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. , 1996, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[23]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[24]  S. Dovey,et al.  Antibiotic use in upper respiratory tract infections in New Zealand. , 1995, Family practice.

[25]  L. Kingsley,et al.  Molecular analysis of bacterial pathogens in otitis media with effusion. , 1995, JAMA.

[26]  M. Clarke,et al.  Identifying relevant studies for systematic reviews , 1995, BMJ.

[27]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[28]  A. Raymont,et al.  The Waikato Medical Care (WaiMedCa) Survey 1991-1992. , 1994, The New Zealand medical journal.

[29]  E. Mini,et al.  Adverse Effects of Macrolide Antibacterials , 1993, Drug safety.

[30]  C. Fung,et al.  The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. , 1992, The Journal of antimicrobial chemotherapy.

[31]  K. Hashiguchi,et al.  Seroprevalence of Chlamydia pneumoniae infections in otolaryngeal diseases , 1992, The Journal of Laryngology & Otology.

[32]  G. Doern,et al.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States , 1990, Antimicrobial Agents and Chemotherapy.

[33]  B. Catlin.  Branhamella catarrhalis: an organism gaining respect as a pathogen , 1990, Clinical Microbiology Reviews.

[34]  R. Wallace,,et al.  Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. , 1990, The American journal of medicine.

[35]  G. Hoyne,et al.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia , 1987, Epidemiology and Infection.

[36]  C. Vaughan.  Current concepts in otolaryngology: diagnosis and treatment of organic voice disorders. , 1982, The New England journal of medicine.

[37]  P. Higgins.  Viruses associated with acute respiratory infections 1961–71 , 1974, Journal of Hygiene.

[38]  Ralph Gonzales,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[39]  H. Miörner,et al.  High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. , 1980, Scandinavian journal of infectious diseases.